| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,945 | 25,594 | 27,513 | 29,263 | | Cost of Revenue | 6,817 | 7,714 | 7,159 | 7,591 | | | Gross Profit |
-
| 17,880 | 20,354 | 21,672 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,272 | 16,334 | 14,697 | 9,338 | | Non Recurring | (304) |
-
| 66,846 | 3,413 | | Others | 20,704 | 22,995 | 32,761 | 11,486 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (21,449) | (93,950) | (2,565) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (19,544) | (21,449) | (93,950) | (2,565) | | Interest Expense | 1,760 | 2,039 | 2,194 | 2,601 | | Income Before Tax | (21,304) | (23,488) | (96,144) | (5,166) | | Income Tax Expense | (8,592) | (9,478) | (11,983) | (2,450) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,712) | (14,010) | (84,161) | (2,716) | | | Non-recurring Events | | Discontinued Operations | 285 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,427) | (14,010) | (84,161) | (2,716) | | Preferred Stock And Other Adjustments | (652) | (652) | (322) |
-
| | | Net Income Applicable To Common Shares | ($13,079) | ($14,662) | ($84,483) | ($2,716) |
|
0.11% Nasdaq 
0.24%
Income Statement
